Son, Ameril A.

HRN: 14-30-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/16/2025
08/23/2025
IV
2.25G
Q6HRS
SEPSIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines